Eduardo Aluicio-Sarduy1, Todd E Barnhart1, Jamey Weichert2, Reinier Hernandez1,2, Jonathan W Engle3,2. 1. Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin; and. 2. Department of Radiology, University of Wisconsin-Madison, Madison, Wisconsin. 3. Department of Medical Physics, University of Wisconsin-Madison, Madison, Wisconsin; and wengle@wisc.edu.
Abstract
The aim of this work was to explore 132La as a PET imaging surrogate for 225Ac using a DOTA-based, tumor-targeting alkylphosphocholine (NM600). Methods: 132La was produced on a biomedical cyclotron. For in vivo experiments, mice bearing 4T1 tumors were administered 132La-NM600, and PET/CT scans were acquired up to 24 h after injection. After the last time point, the ex vivo tissue distribution was measured to corroborate the in vivo PET data. The ex vivo tissue distribution in mice was determined at 4 and 24 h after injection of 225Ac-NM600. Results: PET/CT images showed elevated, persistent 132La-NM600 uptake in the tumor. Low bone accumulation confirmed the in vivo stability of the conjugate. Ex vivo biodistribution studies validated the image-derived quantitative data, and the comparison of the 132La-NM600 and 225Ac-NM600 tissue distributions revealed a similar biodistribution for the 2 radiotracers. Conclusion: These findings suggest that 132La is a suitable imaging surrogate to probe the in vivo biodistribution of 225Ac radiotherapeutics.
The aim of this work was to explore 132La as a PET imaging surrogate for 225Ac using a DOTA-based, tumor-targeting alkylphosphocholine (NM600). Methods: 132La was produced on a biomedical cyclotron. For in vivo experiments, mice bearing 4T1 tumors were administered 132La-NM600, and PET/CT scans were acquired up to 24 h after injection. After the last time point, the ex vivo tissue distribution was measured to corroborate the in vivo PET data. The ex vivo tissue distribution in mice was determined at 4 and 24 h after injection of 225Ac-NM600. Results: PET/CT images showed elevated, persistent 132La-NM600 uptake in the tumor. Low bone accumulation confirmed the in vivo stability of the conjugate. Ex vivo biodistribution studies validated the image-derived quantitative data, and the comparison of the 132La-NM600 and 225Ac-NM600 tissue distributions revealed a similar biodistribution for the 2 radiotracers. Conclusion: These findings suggest that 132La is a suitable imaging surrogate to probe the in vivo biodistribution of 225Ac radiotherapeutics.
Authors: Mike Sathekge; Frank Bruchertseifer; Mariza Vorster; Ismaheel Lawal; Otto Knoesen; Johncy Mahapane; Cindy Davis; Florette Reyneke; Alex Maes; Clemens Kratochwil; Thabo Lengana; Frederik Giesel; Christophe Van de Wiele; Alfred Morgenstern Journal: J Nucl Med Date: 2019-05-17 Impact factor: 10.057
Authors: Eduardo Aluicio-Sarduy; Nikki A Thiele; Kirsten E Martin; Brett A Vaughn; Justin Devaraj; Aeli P Olson; Todd E Barnhart; Justin J Wilson; Eszter Boros; Jonathan W Engle Journal: Chemistry Date: 2020-01-09 Impact factor: 5.236
Authors: Jan de Swart; Ho Sze Chan; Marlies C Goorden; Alfred Morgenstern; Frank Bruchertseifer; Freek J Beekman; Marion de Jong; Mark W Konijnenberg Journal: J Nucl Med Date: 2015-12-03 Impact factor: 10.057
Authors: Nikki A Thiele; Victoria Brown; James M Kelly; Alejandro Amor-Coarasa; Una Jermilova; Samantha N MacMillan; Anastasia Nikolopoulou; Shashikanth Ponnala; Caterina F Ramogida; Andrew K H Robertson; Cristina Rodríguez-Rodríguez; Paul Schaffer; Clarence Williams; John W Babich; Valery Radchenko; Justin J Wilson Journal: Angew Chem Int Ed Engl Date: 2017-10-16 Impact factor: 15.336
Authors: Alfred Morgenstern; Christos Apostolidis; Clemens Kratochwil; Mike Sathekge; Leszek Krolicki; Frank Bruchertseifer Journal: Curr Radiopharm Date: 2018
Authors: Reinier Hernandez; Kirsti L Walker; Joseph J Grudzinski; Eduardo Aluicio-Sarduy; Ravi Patel; Christopher D Zahm; Anatoly N Pinchuk; Christopher F Massey; Ariana N Bitton; Ryan J Brown; Paul M Sondel; Zachary S Morris; Jonathan W Engle; Christian M Capitini; Jamey P Weichert Journal: Commun Biol Date: 2019-02-26
Authors: Eduardo Aluicio-Sarduy; Reinier Hernandez; Aeli P Olson; Todd E Barnhart; Weibo Cai; Paul A Ellison; Jonathan W Engle Journal: Sci Rep Date: 2019-07-23 Impact factor: 4.379
Authors: Reinier Hernandez; Joseph J Grudzinski; Eduardo Aluicio-Sarduy; Christopher F Massey; Anatoly N Pinchuk; Ariana N Bitton; Ravi Patel; Ray Zhang; Aakarsha V Rao; Gopal Iyer; Jonathan W Engle; Jamey P Weichert Journal: J Nucl Med Date: 2019-12-20 Impact factor: 10.057
Authors: Bryce J B Nelson; Simon Ferguson; Melinda Wuest; John Wilson; M John M Duke; Susan Richter; Hans Soenke-Jans; Jan D Andersson; Freimut Juengling; Frank Wuest Journal: J Nucl Med Date: 2021-08-12 Impact factor: 10.057